Press release Oblique Therapeutics has been recognized as one of the 15 most promising Biotech startups in Europe…
Read moreWe would like to welcome our new international- as well as Scandinavian owners after closing this funding round.
Read moreOblique Therapeutics has entered into a collaboration agreement with a mid-sized Pharma for the development of the TRPV1…
Read moreOblique Therapeutics opens office in Stockholm, Sweden, expanding operations to the capital. The headquarter will remain in Gothenburg,…
Read moreWe are recruiting for a SVP-Head of Biologics Development. Read more about the role by downloading this file
Read more